American Century Companies Inc. Sells 391,004 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

American Century Companies Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,614,791 shares of the healthcare conglomerate's stock after selling 391,004 shares during the quarter. UnitedHealth Group makes up approximately 0.5% of American Century Companies Inc.'s investment portfolio, making the stock its 23rd largest position. American Century Companies Inc. owned about 0.18% of UnitedHealth Group worth $816,858,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the company. Plancorp LLC raised its holdings in UnitedHealth Group by 15.4% in the fourth quarter. Plancorp LLC now owns 12,805 shares of the healthcare conglomerate's stock valued at $6,478,000 after acquiring an additional 1,711 shares in the last quarter. Runnymede Capital Advisors Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth $70,000. Cyrus J. Lawrence LLC raised its holdings in shares of UnitedHealth Group by 5.2% in the fourth quarter. Cyrus J. Lawrence LLC now owns 611 shares of the healthcare conglomerate's stock valued at $309,000 after buying an additional 30 shares during the last quarter. Mizuho Securities USA LLC increased its position in UnitedHealth Group by 45.7% in the 4th quarter. Mizuho Securities USA LLC now owns 87,222 shares of the healthcare conglomerate's stock valued at $44,122,000 after acquiring an additional 27,343 shares during the period. Finally, ZEGA Investments LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $5,358,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Remove Ads

UnitedHealth Group Trading Up 0.9 %

Shares of UnitedHealth Group stock traded up $4.67 during trading hours on Wednesday, hitting $518.10. The company's stock had a trading volume of 3,253,715 shares, compared to its average volume of 4,086,604. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a 50 day moving average of $509.10 and a 200 day moving average of $545.56. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market capitalization of $473.92 billion, a PE ratio of 33.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group's payout ratio is 54.19%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on UNH shares. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.